Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO)
NCT04712344
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
58
Enrollment
OTHER
Sponsor class
Conditions
Severe COVID-19
Interventions
BIOLOGICAL:
COVID-19 convalescent plasma
Sponsor
University of Erlangen-Nürnberg Medical School